Lit-Control Devicare pH Up Mechanism of Action

Greater efficacy: Synergic effect between theobromine and urine alkalinisation.
Theobromine: first specific inhibitor of uric acid crystallisation.
Increases the time to uric acid crystallisation 12.6-fold.
New alkalinising formulation: increased calcium oxalate inhibiting capacity. Formulated with magnesium citrate and potassium citrate.
Recommended by the EAU Guidelines.
Lesser risk of adverse effects: magnesium citrate & potassium citrate.
Improved adherence to therapy.
Lesser amount of potassium.
Composition and actions: Urine alkalinising agent (citrates), calcium oxalate crystallisation inhibitor (citrates and magnesium).
Theobromine: Specific uric acid crystallisation inhibitor.
Zinc: Maintains body acid-base homeostasis.
Vitamin A: Crystallisation inhibitors.